This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HUGH REYNOLDS, M.B. B.Ch.; CLARENCE S. LIVINGOOD, M.D.

AMA Arch Derm. 1959;80(4):407-409.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Relaxin^* was discovered by Hishaw,¹ in 1926. He noted that injection of the serum of pregnant rabbits into virgin guinea pigs produced relaxation of the pubic symphysis.

The use of relaxin in the treatment of scleroderma was proposed by Casten and Boucek.² They stressed its advantages in the management of the disabling peripheral vascular symptoms, which are such a distressing feature of the systemic form of the disease.

On the basis of their report we used relaxin in the treatment of two patients who presented with severe Raynaud's phenomenon and who had associated trophic ulceration and gangrene.

Report of Cases

CASE 1.—A housewife, aged 57 years, was admitted to the Henry Ford Hospital on July 17, 1957. Her chief complaints were as follows:

1. Raynaud's phenomenon of three years' duration;
   
2. Weakness, becoming progressively worse during the preceding six months and affecting primarily the
   

Author Affiliations
Mobile, Ala.; Detroit

From the Department of Dermatology, Henry Ford Hospital (Clarence S. Livingood M.D., Chairman).

Footnotes
Submitted for publication Feb. 14, 1959.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?